Healthcare coverage affects survival of egfr-mutant thai lung cancer patients

HIGHLIGHTS

• who: Khantong Khiewngam et al. from the Yerevan State University, Armenia National Center Hospital, Japan have published the Article: Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients, in the Journal: (JOURNAL) of 30/04/2017
• how: The results showed that for EGFRm-positive NSCLC patients who received EGFR-TKI treatment real-world clinical outcomes (median OS approximately 35 months median TTF approximately 12 months) were comparable with those reported in other countries .
• future: In contrast EGFRm-negative NSCLC patients (who are not considered to benefit from EGFR-TKI therapy) the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.